Citations

Showing 10 of 108083 citations.

Determinants of Survival and Retrospective Comparisons in 183 Clinical Trial Patients with Myelofibrosis Treated with Ruxolitinib, Fedratinib, Momelotinib, or BMS-911543 JAK2 Inhibitor between 2007 and 2013
Gangat, Naseema , Begna, Kebede H. , Al‐Kali, Aref , Litzow, Mark R. , Pardanani, Animesh , Tefferi, Ayalew , Hogan, William J.

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3945-3946

10.1182/blood-2022-160179 Get It

Newly Diagnosed, Untreated, Multiple Myeloma (MM) Patient Samples Already Harbor Cereblon (CRBN) Exon 10 Deletions Associated with Drug Resistance
Zhu, Yuan Xiao , Ahmann, Gregory , Bruins, Laura A., Arribas, Mariano , Chen, Xianfeng , Chesi, Marta, Chesi, Marta , Bergsagel, P. Leif , Fonseca, Rafaël , Rimsza, Lisa M.

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4187-4188

10.1182/blood-2022-157316 Get It

A Phase 1a/b Dose Escalation Study of the BTK/FLT3 Inhibitor Luxeptinib in Patients with Relapsed or Refractory B-Cell Malignancies
Samaniego, Felipe , Sadiq, Ahad A., Mahadevan, Daruka , Koontz, Michael Zach, Burke, John M. , Cherry, Mohamad , Melear, Jason M., Priego, Victor, Cobb, Patrick , Cull, Elizabeth H., Conkling, Paul , Cosgrove, David , Haney, Donna Nguyen, Hu, Jia, Rice, William G. , Bejar, Rafael, Villasboas, José C. , Reid, Erin G , Roeker, Lindsey E. , Sinha, Ranjeet Kumar , Bejar, Rafael

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6498-6500

10.1182/blood-2022-163683 Get It

Treatment Preferences of Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States, United Kingdom, France, Spain, Italy, and Germany: Results from a Discrete Choice Experiment
Popat, Rakesh , Kleinman, David , Perera, Sue , Gorsh, Boris , Mulnick, Sarah, O'Neill, Alicia, Paka, Prani , Hanna, Maya, Molinari, Alexa , Naine, Shivaranjani, Gelhorn, Heather L. , Popat, Rakesh , Ailawadhi, Sikander , Thomas, Caitlin , Ross, Melissa

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7211-7213

10.1182/blood-2022-164795 Get It

Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) +/- Daratumumab Treatment Results in Sustained Hematologic Response in Patients with AL Amyloidosis: A Retrospective Analysis of Patients at Mayo Clinic
Kusne, Yael , Arribas, Mariano , Klanderman, Molly, Wiedmeier, Julia E. , Reeder, Craig B. , Larsen, Jeremy T. , Rosenthal, Julie , Wiedmeier-Nutor, Julia E , Fonseca, Rodrigo , Bergsagel, P. Leif , Fonseca, Rafaël

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7224-7225

10.1182/blood-2022-166668 Get It

Prevalence of Monoclonal Gammopathies Detected By Mass Spectrometry and Their Risk Factors Among Black Africans in South Africa
Bertamini, Luca, Perry, Jacqueline , Barnidge, David R. , Perkins, Mark, Troske, Derek, Pentz, Audrey , Hlubi, Thulisile, Smyth, Natalie , Cowan, Anna, Tramontano, Angela C. , Lee, David Jungpa , El‐Khoury, Habib , Bertamini, Luca , Alberge, Jean-Baptiste , Davis, Maya , Sakrikar, Dhananjay , Harding, Stephen E. , Getz, Gad , Rebbeck, Timothy R. , Joffe, Maureen , Chen, Wenlong Carl , Marinac, Catherine R. , Ghobrial, Irene M.

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7228-7229

10.1182/blood-2022-167268 Get It

Artificial Intelligence-Enhanced Models to Predict Light Chain Amyloidosis from Patients with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Dasari, Surendra , Grogan, Martha , Lacy, Martha Q. , Kourelis, Taxiarchis , Attia, Itzhak Z., Lopez‐Jimenez, Francisco, Murphree, Dennis H. , Friedman, Paul A. , Kumar, Shaji , Muchtar, Eli , Gertz, Morie A. , Buadi, Francis K. , Dingli, David , Attia, Itzhak Z., López-Jiménez, Francisco , Dispenzieri, Angela

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7230-7232

10.1182/blood-2022-168119 Get It

Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+Treated with Daratumumab-Based Regimens: A Retrospective Analysis
Gardner, Lindsay B., Moustafa, Mohamad Alhaj, Sher, Taimur , Rasheed, Ahsan , Warsame, Rahma , Larsen, Jeremy T. , Kourelis, Taxiarchis , Kapoor, Prashant , Chanan‐Khan, Asher , Parrondo, Ricardo D , Roy, Vivek , Gonsalves, Wilson I. , Fonseca, Rafaël , Ailawadhi, Sikander

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7237-7238

10.1182/blood-2022-169533 Get It

Potential Drivers of Acquired Resistance to Idelalisib in CLL Patients
Yadav, Saurabh, Furman, Richard R. , Brown, Jennifer R. , Khalsa, Jasneet Kaur , Murali, Ishwarya , Kay, Neil E. , Braggio, Esteban

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12373-12374

10.1182/blood-2022-166648 Get It